# Bridgepoint Master Audit Report - Findings Tracking

## Priority Queue (Top 10 - Must Be Addressed This Week)

### Status Overview
- **Completed**: 8/10
- **In Progress**: 0/10
- **Pending**: 2/10

### Priority 1: Finding 1 — camt.056 not claimed in provisional spec
**Category**: Patent Legal Vulnerabilities | **Severity**: CRITICAL
- **Source**: `01_provisional_spec_v4.md`, Claims Section
- **What's needed**: Add dependent claim D13 to provisional spec before utility conversion
- **Status**: ✅ COMPLETED (v5.2)
- **Action**: Brief patent attorney as Month 1 action; add claim element
- **Resolved**: 2026-04-21 — Dependent Claim D13 added with full claim text covering camt.056 detection, ML classifier, security interest preservation workflow

### Priority 2: Finding 36 — Internal contradiction in SSRN submission timing
**Category**: Logical/Factual Inconsistencies | **Severity**: CRITICAL
- **Source**: Playbook Phase 2.1 vs. Non-Negotiable Calendar
- **What's needed**: Fix Phase 2.1 instruction to match hard deadline
- **Status**: ✅ COMPLETED
- **Action**: Replace "immediate next step" language with March 2027 timeline
- **Resolved**: 2026-04-21 — Section 2.1 corrected: paper ready but will post PFD + 13mo after utility filing

### Priority 3: Finding 3 — Claims 2 and 3 lack Amendment B trigger distinction
**Category**: Patent Legal Vulnerabilities | **Severity**: CRITICAL
- **Source**: `01_provisional_spec_v4.md`, Independent Claims 2 and 3
- **What's needed**: Add trigger-distinction language to Claims 2 and 3
- **Status**: ✅ COMPLETED (v5.2)
- **Action**: Add "exclusively by real-time detection" language before utility filing
- **Resolved**: Amendment B in v5.2 added trigger-distinction to Claim 2 (element i-a) and Claim 3 (element j-pre). Both claims now have equivalent protection against Bottomline §103.

### Priority 4: Finding 10 — FTD missing P3 multi-party description
**Category**: Patent Portfolio Strategic Gaps | **Severity**: CRITICAL
- **Source**: `03_future_technology_disclosure.md`
- **What's needed**: Add Section F describing multi-party distributed implementation
- **Status**: ✅ COMPLETED (v2.1 Extension F)
- **Action**: Write Section F with technical details before commercial conversations begin
- **Resolved**: Extension F in v2.1 already includes comprehensive multi-party distributed architecture description (three-entity framework: MLO, MIPLO, ELO; API specifications; legal structure)

### Priority 5: Finding 2 — Claim 4 vulnerable to Bottomline §103
**Category**: Patent Legal Vulnerabilities | **Severity**: CRITICAL
- **Source**: `01_provisional_spec_v4.md`, Independent Claim 4
- **What's needed**: Add claim element differentiating from Bottomline architecture
- **Status**: ✅ COMPLETED (v5.2 / v5.3 follow-up)
- **Action**: Amend step (p) to reference specific identifiable transactions
- **Resolved**: Claim 4 in the current provisional uses specific individually identified anticipated payment events rather than anonymous aggregate forecasting, and the patent family architecture now explicitly distinguishes P2 Claim 4 from P4 embodiment claims.

### Priority 6: Finding 25 — $88 billion/day arithmetic error in investor briefing
**Category**: Investor Briefing Accuracy/Legal Risk | **Severity**: CRITICAL
- **Source**: `Liquidity_Intelligence_Platform_Investor_Briefing.docx`
- **What's needed**: Replace $88B with $3.5B (correct calculation)
- **Status**: ✅ COMPLETED (v2.1 correction)
- **Action**: Global find-replace before any distribution
- **Resolved**: 2026-04-21 — corrected to "$88B in transit; $2.6B-$4.4B stuck"

### Priority 7: Finding 26 — "Patented" misrepresentation in investor briefing
**Category**: Investor Briefing Accuracy/Legal Risk | **Severity**: CRITICAL
- **Source**: `Liquidity_Intelligence_Platform_Investor_Briefing.docx`
- **What's needed**: Replace "patented" with "patent-pending" throughout
- **Status**: ✅ COMPLETED (v2.2 correction)
- **Action**: Global find-replace; add footnote explaining provisional status
- **Resolved**: 2026-04-21 — all instances corrected; v2.2 includes provisional status footnote

### Priority 8: Finding 39 — AML/KYC compliance architecture absent
**Category**: Missed Opportunities | **Severity**: CRITICAL
- **Source**: All documents (absent throughout)
- **What's needed**: Add Section 9 on compliance architecture to paper and playbook
- **Status**: ✅ COMPLETED
- **Action**: Document compliance exclusion logic and KYC screening procedures
- **Resolved**: 2026-04-21 — Added Section 8.3 "Compliance Architecture and Regulatory Considerations" to academic paper v2.1. Covers: compliance hold vs. operational delay classification, BLOCK code exclusion logic, KYC/AML screening for borrowers, and SAR reporting obligations.

### Priority 9: Finding 40 — Lending licence requirements not assessed
**Category**: Missed Opportunities | **Severity**: CRITICAL
- **Source**: All documents (absent throughout)
- **What's needed**: Obtain regulatory opinion on BC lending licence requirement
- **Status**: ⏳ PENDING
- **Action**: Consult Canadian financial services regulation lawyer within 30 days

### Priority 10: Finding 4 — Micro-entity status not validated
**Category**: Patent Legal Vulnerabilities | **Severity**: HIGH
- **Source**: `01_provisional_spec_v4.md`, Section 1
- **What's needed**: Confirm micro-entity eligibility with patent attorney
- **Status**: ⏳ PENDING
- **Action**: Verify income threshold and filing history before utility filing

---

## Category 1: Patent Legal Vulnerabilities (Findings 1-9)

### Status Overview
- **Completed**: 7/9
- **In Progress**: 0/9
- **Pending**: 2/9

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 1 | camt.056 not claimed in provisional spec | CRITICAL | ✅ COMPLETED (v5.2) |
| 2 | Claim 4 vulnerable to Bottomline §103 | CRITICAL | ✅ COMPLETED (v5.2) |
| 3 | Claims 2 and 3 lack Amendment B trigger | CRITICAL | ✅ COMPLETED (v5.2) |
| 4 | Micro-entity status not validated | HIGH | ⏳ PENDING |
| 5 | "Exclusively" language over-narrowing | HIGH | ⏳ PENDING |
| 6 | Claim 5 implicitly dependent (missing disbursement step) | HIGH | ✅ COMPLETED (v5.3) |
| 7 | Alice §101 analysis missing for Claims 3 and 4 | HIGH | ✅ COMPLETED (v5.3) |
| 8 | NLP claim element lacks written description support | MEDIUM | ✅ COMPLETED (v5.3) |
| 9 | Combination pre-emption missing US20250086644A1 address | MEDIUM | ✅ COMPLETED (v5.3) |

---

## Category 2: Patent Portfolio Strategic Gaps (Findings 10-17)

### Status Overview
- **Completed**: 6/8
- **In Progress**: 0/8
- **Pending**: 2/8

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 10 | FTD missing P3 multi-party description | CRITICAL | ✅ COMPLETED (v2.1) |
| 11 | FTD missing camt.056 mechanism description | CRITICAL | ✅ COMPLETED (v2.1 Extension G) |
| 12 | P3 filing year inconsistent (18-24mo vs 2028) | HIGH | ✅ COMPLETED (calendar clarified) |
| 13 | P4 scope overlap with P2 Claim 4 unclear | HIGH | ✅ COMPLETED (architecture clarified) |
| 14 | Pre-emptive cascade prevention not covered | HIGH | ✅ COMPLETED (FTD v2.1 B.4) |
| 15 | Hong Kong and Japan absent from PCT filing | HIGH | ✅ COMPLETED (architecture / provisional strategy updated) |
| 16 | No claim covering trade secret generation method | HIGH | ✅ COMPLETED (P12 scope expanded) |
| 17 | CIP vs continuation status unclear for P6, P7, P8 | HIGH | ⏳ PENDING — counsel decision remains required |

---

## Category 3: Technical and Scientific Accuracy (Findings 18-24)

### Status Overview
- **Completed**: 7/7
- **In Progress**: 0/7
- **Pending**: 0/7

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 18 | Isotonic regression superiority not numerically supported | HIGH | ✅ COMPLETED (pre/post ECE documented) |
| 19 | AUC reported without baseline comparison | HIGH | ✅ COMPLETED (baseline section added) |
| 20 | Dataset description missing key details | HIGH | ✅ COMPLETED (synthetic corpus details added) |
| 21 | Section 4.3 ends mid-sentence (incomplete) | HIGH | ✅ COMPLETED (method section rewritten) |
| 22 | "Sub-100ms" latency claim imprecise vs p99 data | HIGH | ✅ COMPLETED (45/94 target language aligned) |
| 23 | Reference list incomplete ([12]-[22] missing) | HIGH | ✅ COMPLETED |
| 24 | No retraining pipeline or model drift monitoring | MEDIUM | ✅ COMPLETED (governance section added) |

---

## Category 4: Investor Briefing Accuracy and Legal Risk (Findings 25-30)

### Status Overview
- **Completed**: 6/6
- **In Progress**: 0/6
- **Pending**: 0/6

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 25 | $88B/day arithmetic error (25× overstatement) | CRITICAL | ✅ COMPLETED (v2.1) |
| 26 | "Patented" misrepresentation (provisional ≠ patent) | CRITICAL | ✅ COMPLETED (v2.2) |
| 27 | "Proven" misrepresents dataset-only validation | HIGH | ✅ COMPLETED (synthetic-validation language corrected) |
| 28 | Royalty projections don't reconcile with assumptions | HIGH | ✅ COMPLETED (addressable volume / royalty notes added) |
| 29 | "Patent-protected until 2058" misstates core expiry | HIGH | ✅ COMPLETED (core 2047 / continuation ~2058 distinction added) |
| 30 | Live output table conflates PD with failure prob | HIGH | ✅ COMPLETED (Stage 1 vs Stage 2 note added) |

---

## Category 5: Deal Structure and Commercial Strategy Gaps (Findings 31-32)

### Status Overview
- **Completed**: 2/2
- **In Progress**: 0/2
- **Pending**: 0/2

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 31 | Voluntary MFN clause recommendation is dangerous | HIGH | ✅ COMPLETED |
| 32 | $5M advance pool capital source unidentified | HIGH | ✅ COMPLETED |

---

## Category 6: Canadian Regulatory and Tax Compliance Gaps (Findings 33-35)

### Status Overview
- **Completed**: 3/3
- **In Progress**: 0/3
- **Pending**: 0/3

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 33 | Section 85 rollover "elected amount" not specified | HIGH | ✅ COMPLETED |
| 34 | SR&ED eligibility may not survive CRA tightening | MEDIUM | ✅ COMPLETED |
| 35 | GST/HST treatment of patent royalties unaddressed | MEDIUM | ✅ COMPLETED |

---

## Category 7: Logical and Factual Inconsistencies Across Documents (Findings 36-38)

### Status Overview
- **Completed**: 3/3
- **In Progress**: 0/3
- **Pending**: 0/3

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 36 | SSRN submission internal contradiction | CRITICAL | ✅ COMPLETED |
| 37 | FTD title/table inconsistent (4 vs 5 extensions) | MEDIUM | ✅ COMPLETED |
| 38 | "Addressable bridge volume" undefined in projections | MEDIUM | ✅ COMPLETED |

---

## Category 8: Missed Opportunities (Findings 39-46)

### Status Overview
- **Completed**: 7/8
- **In Progress**: 0/8
- **Pending**: 1/8

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 39 | AML/KYC compliance architecture absent | CRITICAL | ✅ COMPLETED (v2.1) |
| 40 | Lending licence requirements not assessed | CRITICAL | ⏳ PENDING |
| 41 | Cross-jurisdictional receivable assignment unaddressed | CRITICAL | ✅ COMPLETED |
| 42 | FX risk premium absent from pricing formula | HIGH | ✅ COMPLETED |
| 43 | SWIFT Technology Partner programme not pursued | HIGH | ✅ COMPLETED |
| 44 | BIS Innovation Hub engagement absent | HIGH | ✅ COMPLETED |
| 45 | CCO hire vs advisor-only model unanalyzed | HIGH | ✅ COMPLETED |
| 46 | Employment agreement template missing IP assignment | HIGH | ✅ COMPLETED |

---

## Category 9: Discussed in Conversation, Not in Documents (Findings 47-48)

### Status Overview
- **Completed**: 2/2
- **In Progress**: 0/2
- **Pending**: 0/2

| # | Finding | Severity | Status |
|---|---------|----------|--------|
| 47 | camt.056 mechanism recognized but not claimed | CRITICAL | ✅ COMPLETED |
| 48 | Competitive fear insight not operationalized in messaging | HIGH | ✅ COMPLETED |

---

## Summary Statistics

| Category | Total | Critical | High | Medium |
|----------|-------|----------|------|--------|
| 1. Patent Legal Vulnerabilities | 9 | 5 | 4 | 0 |
| 2. Patent Portfolio Strategic Gaps | 8 | 2 | 6 | 0 |
| 3. Technical/Scientific Accuracy | 7 | 0 | 6 | 1 |
| 4. Investor Briefing Accuracy/Legal Risk | 6 | 2 | 4 | 0 |
| 5. Deal Structure/Commercial Strategy | 2 | 0 | 2 | 0 |
| 6. Canadian Regulatory/Tax Compliance | 3 | 0 | 1 | 2 |
| 7. Logical/Factual Inconsistencies | 3 | 1 | 0 | 2 |
| 8. Missed Opportunities | 8 | 3 | 5 | 0 |
| 9. Discussed Not in Documents | 2 | 1 | 1 | 0 |
| **TOTAL** | **48** | **14** | **29** | **5** |

**Completion**: 42/48 (87.5%)
**Estimated Remaining Implementation Time**: ~6-12 hours plus external legal review time

*Last Updated:* 2026-04-22
